FBRX
Forte Biosciences, Inc.Company with tickers: FBRX
CIK
1419041
CUSIP
34962G208
Shares Outstanding
20,478,817
13F Activity (30d)
68 filings
68 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $22,439,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Research & Development | — | ||||
| Operating Income | $-22,439,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-22,136,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-1.24 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-1.24 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |